Membranoproliferative GN II

Injury	Disease	Nutrition	Poison

Symptoms	Surgery	Test	Special Topic

Kidney anatomy

Membranoproliferative GN II

Alternative Names:

Membranoproliferative glomerulonephritis (type II); Glomerulonephritis - membranoproliferative (type II); Mesangiocapillary glomerulonephritis (type II); Dense deposit disease; MPGN II
Treatment:

Treatmentvariesaccording to the symptoms. The goals of treatment are to reducesymptoms, prevent complications, and slow the worseningof the disorder.

text continues below

Dietary adjustments may include restrictions on sodium, fluids, protein, or other restrictions to control high blood pressure, swelling, and accumulation of waste products in the bloodstream.

Antihypertensive medications may be vital to help control blood pressure. Diuretics or other medications may be needed to control swelling or other symptoms.

Dialysis or kidney transplantation may eventually be required to manage renal failure.

Expectations (prognosis):

The disorder progresses slowly to chronic renal failure. Fifty percent of cases will develop chronic renal failure within 10 years.

Complications:

Calling your health care provider:

Call for an appointment with your health care provider if symptoms indicate MPGN II.

Call for an appointment with your health care provider if symptoms worsen or new symptoms develop, including decreased urine output.